Delivery Order SPE2DB22D1202-SPE2DB25FUSQ7

Award Date 2/12/25
Potential Completion Date 2/13/25
Potential Value $14K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $4,135.61, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CLOBAZAM 10 MG TABLET 100S, a pharmaceutical product, with a period of performance ending on February 5, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,553.82 firm fixed-price delivery order is for the supply of 4562781064 - CLOBAZAM 10 MG TABLET 100S, with a completion date of November 13, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,751.63, is for the provision of 4567254136 ! CLOBAZAM 10 MG TABLET 100S, a pharmaceutical product. The contract is a firm fixed-price award with a completion date of February 13, 2025. It is not designated as a set-aside contract. Amerisourcebergen Drug Corp is the prime...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,275.60 fixed-price delivery order is for the supply of 4563636579 CLOBAZAM 10 MG TABLET 100S, with a completion date of February 13, 2024. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,759.57, is for the delivery of 4562661892 CLOBAZAM 10 MG TABLET 100S and has an ultimate completion date of November 1, 2023. This award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,831.20 firm fixed-price delivery order is for the supply of 4566691271 - CLOBAZAM 10 MG TABLET 100S. The contract has an ultimate completion date of December 12, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The firm-fixed-price delivery order, valued at $2,042.53, is for the supply of CLOBAZAM 10 MG TABLET 100S. This award is not associated with a set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the delivery of CLOBAZAM 10 MG TABLET 100S. The contract has a ceiling value of $6,325.69 and a period of performance through December 12, 2024. It is a firm fixed-price delivery order contract, with no set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,779.65, is for the delivery of 4566422120 CLOBAZAM 10 MG TABLETs. It is a firm fixed-price delivery order contract with a completion date of November 14, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award with ID SPE2DB20D1100|SPE2DB25FA2Y6 was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,166.60 firm fixed-price delivery order contract is for the delivery of 4567072342 CLOBAZAM 10 MG TABLET 100S, with a performance period through January 29, 2025. The contract is not designated with any set-aside requirements, indicating open competition....
  • SPE2DB22D1202
    Indefinite Delivery Contract
  • SPE2DB22D1202-SPE2DB25FUSQ7
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,616.82 Firm Fixed Price Delivery Order contract is for the supply of CLOBAZAM 10 MG TABLET 100S, a pharmaceutical product, with a completion date of February 13, 2025.

The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This IDC covers critical medical commodities such as specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. The contract does not have a set-aside designation, indicating open competition.

Generated 5/14/25, 9:42 AM